{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:40:09Z","timestamp":1789501209711,"version":"build-2803163510"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Using published data, we found a direct correlation between the incidence of rectal gonorrhea and human immunodeficiency virus (HIV) infection in men who have sex with men who were not using oral preexposure prophylaxis. HIV incidence was predicted using rectal gonorrhea incidence as the determinant in regression analysis. The observed correlation suggest that rectal gonorrhea incidence can potentially serve as a predictor of HIV incidence. If confirmed with additional data, a quantitative correlation for incidence of the 2 infections could be useful in active-controlled HIV prevention trials where low HIV incidence is expected. Widespread improvements in treatment as prevention and gonorrhea control can negatively impact the correlation and its utility.<\/jats:p>","DOI":"10.1093\/infdis\/jiz037","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T05:39:13Z","timestamp":1547876353000},"page":"214-217","source":"Crossref","is-referenced-by-count":31,"title":["Correlations Between Human Immunodeficiency Virus (HIV) Infection and Rectal Gonorrhea Incidence in Men Who Have Sex With Men: Implications for Future HIV Preexposure Prophylaxis Trials"],"prefix":"10.1093","volume":"221","author":[{"given":"Charu","family":"Mullick","sequence":"first","affiliation":[{"name":"Division of Antiviral Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Murray","sequence":"additional","affiliation":[{"name":"Division of Antiviral Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"key":"2019123007075676300_CIT0001","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"2019123007075676300_CIT0002","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"2019123007075676300_CIT0003","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"key":"2019123007075676300_CIT0004","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"Molina","year":"2015","journal-title":"N Engl J Med"},{"key":"2019123007075676300_CIT0005","volume-title":"HIV prevention research and development database","author":"AVAC\u2014Global Advocacy for HIV Prevention"},{"key":"2019123007075676300_CIT0006","article-title":"HIV incidence in persons using Truvada (FTC\/TDF) for HIV pre-exposure prophylaxis (PrEP): worldwide experience from 46 studies","volume-title":"HIV Research for Prevention,","author":"Baeten","year":"2018"},{"key":"2019123007075676300_CIT0007","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15284336.2017.1379676","article-title":"HIV prevention trial design in an era of effective pre-exposure prophylaxis","volume":"18","author":"Cutrell","year":"2017","journal-title":"HIV Clin Trials"},{"key":"2019123007075676300_CIT0008","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1086\/508460","article-title":"Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study","volume":"43","author":"Morris","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2019123007075676300_CIT0009","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/QAI.0b013e3181b48f33","article-title":"Anal sexually transmitted infections and risk of HIV infection in homosexual men","volume":"53","author":"Jin","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019123007075676300_CIT0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/QAI.0000000000000667","article-title":"HIV and sexually transmitted infection incidence and associated risk factors among high-risk MSM and male-to-female transgender women in Lima, Peru","volume":"69","author":"Castillo","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019123007075676300_CIT0011","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1089\/aid.2015.0013","article-title":"The effect of high rates of bacterial sexually transmitted infections on HIV incidence in a cohort of black and white men who have sex with men in Atlanta, Georgia","volume":"31","author":"Kelley","year":"2015","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2019123007075676300_CIT0012","doi-asserted-by":"crossref","first-page":"e0158310","DOI":"10.1371\/journal.pone.0158310","article-title":"Project gel a randomized rectal microbicide safety and acceptability study in young men and transgender women","volume":"11","author":"McGowan","year":"2016","journal-title":"PLoS One"},{"key":"2019123007075676300_CIT0013","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/sextrans-2016-052865","article-title":"High HIV incidence in men who have sex with men following an early syphilis diagnosis: is there room for pre-exposure prophylaxis as a prevention strategy","volume":"93","author":"Girometti","year":"2017","journal-title":"Sex Transm Infect"},{"key":"2019123007075676300_CIT0014","volume-title":"HIV surveillance report","author":"Centers for Disease Control and Prevention","year":"2016"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/221\/2\/214\/31634708\/jiz037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/221\/2\/214\/31634708\/jiz037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T12:08:05Z","timestamp":1577707685000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/221\/2\/214\/5304966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,1,31]]},"published-print":{"date-parts":[[2020,1,2]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz037","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,1,15]]},"published":{"date-parts":[[2019,1,31]]}}}